{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:25:32Z","timestamp":1780507532207,"version":"3.54.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Flow Pharma, Inc"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.04.034","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:51:16Z","timestamp":1588031476000},"page":"4464-4475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["An effective CTL peptide vaccine for Ebola Zaire Based on Survivors\u2019 CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design"],"prefix":"10.1016","volume":"38","author":[{"given":"C.V.","family":"Herst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Burkholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Brasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cunha-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.C.H.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Carback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ciotlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rubsamen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2020.04.034_b0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","article-title":"Gapped sequence alignment using artificial neural networks: application to the mhc class i system","volume":"32","author":"Andreatta","year":"2016","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.vaccine.2020.04.034_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/v8050148","article-title":"Aerosol transmission of filoviruses","volume":"9","author":"Mekibib","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.04.034_b0015","doi-asserted-by":"crossref","unstructured":"Bassani-Sternberg Michal, Pletscher-Frankild Sune, Jensen Lars Juhl, Mann Matthias. Mass spectrometry of human leukocyte antigen class i peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics 2015;14(3): 658\u201373. https:\/\/doi.org\/10.1074\/mcp.M114.042812.","DOI":"10.1074\/mcp.M114.042812"},{"key":"10.1016\/j.vaccine.2020.04.034_b0020","doi-asserted-by":"crossref","unstructured":"Bellan Steve E, Pulliam Juliet RC, Dushoff , Meyers Lauren Ancel. Ebola control: effect of asymptomatic infection and acquired immunity. The Lancet. 2014;384 (9953): 1499\u2013500. https:\/\/doi.org\/10.1016\/S0140-6736(14)61839-0.","DOI":"10.1016\/S0140-6736(14)61839-0"},{"key":"10.1016\/j.vaccine.2020.04.034_b0025","doi-asserted-by":"crossref","unstructured":"Billeskov R, Wang Y, Solaymani-Mohammadi S, Frey B , Kulkarni S, Andersen, P et al. Low antigen dose in adjuvant-based vaccination selectively induces cd4 t cells with enhanced functional avidity and protective efficacy. J Immunol. 2017;198 (9): 3494\u2013506. https:\/\/doi.org\/10.4049\/jimmunol.1600965.","DOI":"10.4049\/jimmunol.1600965"},{"key":"10.1016\/j.vaccine.2020.04.034_b0030","doi-asserted-by":"crossref","unstructured":"Blicher Thomas, Sandholm Kastrup Jette, Buus Soren, Gajhede Michael. High-resolution structure of hla-a\u2217 1101 in complex with sars nucleocapsid peptide. Acta Crystallographica Section D: Biolog Crystall. 2005;61(8): 1031\u2013040. https:\/\/doi.org\/10.1107\/S0907444905013090.","DOI":"10.2210\/pdb1x7q\/pdb"},{"issue":"2","key":"10.1016\/j.vaccine.2020.04.034_b0035","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human t cells recognizing conserved protein regions inhibit hiv-1","volume":"22","author":"Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2020.04.034_b0040","doi-asserted-by":"crossref","unstructured":"Rodney Brister J, Ako-Adjei Danso, Bao , Blinkova Olga. Ncbi viral genomes resource. Nucleic Acids Res. 2015;43 (D1): D571\u2013577. https:\/\/doi.org\/10.1093\/nar\/gku1207.","DOI":"10.1093\/nar\/gku1207"},{"key":"10.1016\/j.vaccine.2020.04.034_b0045","doi-asserted-by":"crossref","unstructured":"BaslerGaya CF, Amarasinghe K. Evasion of interferon responses by ebola and marburg viruses. J Interferon Cytokine Res. 2009;29(9). https:\/\/doi.org\/10.1089\/jir.2009.0076.","DOI":"10.1089\/jir.2009.0076"},{"key":"10.1016\/j.vaccine.2020.04.034_b0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2013.12.009","article-title":"The sars coronavirus nucleocapsid protein\u2013forms and functions","volume":"103","author":"Chang","year":"2014","journal-title":"Antiviral Res"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2020.04.034_b0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","article-title":"T cell-mediated immune response to respiratory coronaviruses","volume":"59","author":"Channappanavar","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2020.04.034_b0060","doi-asserted-by":"crossref","unstructured":"Ying-Kit Cheung, Samuel Chak-Sum Cheng, Fion Wan-Yee Sin, Kin-Tak Chan, Yong Xie. Induction of t-cell response by a dna vaccine encoding a novel hla-a\u2217 0201 severe acute respiratory syndrome coronavirus epitope. Vaccine. 2007;25(32): 6070\u201377. https:\/\/doi.org\/10.1016\/j.vaccine.2007.05.025.","DOI":"10.1016\/j.vaccine.2007.05.025"},{"key":"10.1016\/j.vaccine.2020.04.034_b0065","first-page":"27","article-title":"Investigation of immunogenic t-cell epitopes in sars virus nucleocapsid protein and their role in the prevention and treatment of sars infection","volume":"14","author":"Cheung","year":"2008","journal-title":"Hong Kong Med J= Xianggang yi xue za zhi"},{"key":"10.1016\/j.vaccine.2020.04.034_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00640","article-title":"An approach for a synthetic ctl vaccine design against zika flavivirus using class i and class ii epitopes identified by computer modeling","author":"Cunha-Neto","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0075","doi-asserted-by":"crossref","DOI":"10.1177\/0300985810378597","article-title":"Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic fever in cynomolgus macaques","author":"Alves","year":"2010","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0080","doi-asserted-by":"crossref","unstructured":"Shishang Dong, Peng Yang, Guobang Li, Baocheng Liu, Wenming Wang, Xiang Liu, et al. Insight into the ebola virus nucleocapsid assembly mechanism: crystal structure of ebola virus nucleoprotein core domain at 1.8 \u00e5 resolution. Protein Cell. 2015;6(5): 351\u201362, ISSN 1674-8018. https:\/\/doi.org\/10.1007\/s13238-015-0163-3.","DOI":"10.1007\/s13238-015-0163-3"},{"key":"10.1016\/j.vaccine.2020.04.034_b0085","doi-asserted-by":"crossref","first-page":"S991","DOI":"10.1093\/infdis\/jir336","article-title":"Host response dynamics following lethal infection of rhesus macaques with zaire ebolavirus","volume":"204","author":"Ebihara","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.04.034_b0090","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/tan.12413","article-title":"Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class i molecules including hla-b\u2217 39: 06","volume":"84","author":"Eichmann","year":"2014","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2020.04.034_b0095","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nri1154","article-title":"Ebola virus: from discovery to vaccine","volume":"3","author":"Feldmann","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0100","doi-asserted-by":"crossref","unstructured":"Frank Steven A, Bush Robin M. Barriers to antigenic escape by pathogens: trade-off between reproductive rate and antigenic mutability. BMC Evol Biol. 2007;7(1): 229. https:\/\/doi.org\/10.1186\/1471-2148-7-229.","DOI":"10.1186\/1471-2148-7-229"},{"key":"10.1016\/j.vaccine.2020.04.034_b0105","doi-asserted-by":"crossref","unstructured":"Rezza G. A vaccine against ebola: Problems and opportunities. Human Vacc Immunotherapeut. 2014;11(5): 1258\u201360. https:\/\/doi.org\/10.1080\/21645515.2015.1021528.","DOI":"10.1080\/21645515.2015.1021528"},{"key":"10.1016\/j.vaccine.2020.04.034_b0110","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.034_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2567.2011.03517.x","article-title":"T-cell-inducing vaccines - what\u2019s the future?","volume":"135","author":"Gilbert","year":"2012","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.vaccine.2020.04.034_b0120","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.4049\/jimmunol.174.7.4198","article-title":"Cd8-mediated protection against ebola virus infection is perforin dependent","volume":"174","author":"Gupta","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic siv by an effector memory t-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.034_b0130","unstructured":"Mikkel Harndahl, Kasper Lamberth, Sune Justesen, Gustav R\u00f8der, Michael Madsen, Christina Sylvester-Hvid, et al. Large scale analysis of peptide-hla class i interactions. IEDB, 2006. URL https:\/\/www.iedb.org\/reference\/1000945."},{"key":"10.1016\/j.vaccine.2020.04.034_b0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00327-3","article-title":"Proinflammatory response during ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily","volume":"80","author":"Hensley","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2020.04.034_b0140","doi-asserted-by":"crossref","unstructured":"Hsueh-Ling Janice Oh, Samuel Ken-En Gan, Antonio Bertoletti, Yee-Joo Tan. Understanding the t cell immune response in sars coronavirus infection. Emerg Microbes Infections. 2012;1(1): 1\u20136. https:\/\/doi.org\/10.1038\/emi.2012.26.","DOI":"10.1038\/emi.2012.26"},{"key":"10.1016\/j.vaccine.2020.04.034_b0145","doi-asserted-by":"crossref","unstructured":"Jones Steven M, Feldmann Heinz, Str\u00f6her Ute, Geisbert Joan B, Fernando Lisa, Grolla Allen, et al. Live attenuated recombinant vaccine protects nonhuman primates against ebola and marburg viruses. Nature Med. 2005;11: 786\u201390. https:\/\/doi.org\/10.1038\/nm1258.","DOI":"10.1038\/nm1258"},{"key":"10.1016\/j.vaccine.2020.04.034_b0150","doi-asserted-by":"crossref","unstructured":"Vanessa Jurtz, Sinu Paul, Massimo Andreatta, Paolo Marcatili, Bjoern Peters, Morten Nielsen. Netmhcpan-4.0: improved peptide\u2013mhc class i interaction predictions integrating eluted ligand and peptide binding affinity data. J Immunol. 2017;199(9): 3360\u201368. https:\/\/doi.org\/10.4049\/jimmunol.1700893.","DOI":"10.4049\/jimmunol.1700893"},{"key":"10.1016\/j.vaccine.2020.04.034_b0155","doi-asserted-by":"crossref","unstructured":"Leffel K, Reed D. Marburg and ebola viruses as aerosol threats. Biosecurity Bioterrorism: Biodefense Strat, Practice, Sci. 2004;2(3). https:\/\/doi.org\/10.1089\/bsp.2004.2.186.","DOI":"10.1089\/bsp.2004.2.186"},{"key":"10.1016\/j.vaccine.2020.04.034_b0160","doi-asserted-by":"crossref","unstructured":"Kalidi I, Fofana Y, Rahly AA, Bochu V, Dehay C, Gony J et al. Study of hla antigens in a population of mali (west africa). Tissue Antigens. 1988;31: 98\u2013102. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3163860.","DOI":"10.1111\/j.1399-0039.1988.tb02070.x"},{"key":"10.1016\/j.vaccine.2020.04.034_b0165","doi-asserted-by":"crossref","unstructured":"Lai Chih-Yun, Strange Daniel P, Wong Teri Ann S, Lehrer Axel T, Verma Saguna. Ebola virus glycoprotein induces an innate immune response in vivo via tlr4. Front Microbiol. 2017; 8:1571. https:\/\/doi.org\/10.3389\/fmicb.2017.01571.","DOI":"10.3389\/fmicb.2017.01571"},{"key":"10.1016\/j.vaccine.2020.04.034_b0170","doi-asserted-by":"crossref","unstructured":"Larkin Mark A, Blackshields Gordon, Brown NP, Chenna R, McGettigan Paul A, McWilliam Hamish, et al. Clustal w and clustal x version 2.0. Bioinformatics. 2007;23(21): 2947\u201348. https:\/\/doi.org\/10.1093\/bioinformatics\/btm404.","DOI":"10.1093\/bioinformatics\/btm404"},{"key":"10.1016\/j.vaccine.2020.04.034_b0175","doi-asserted-by":"crossref","unstructured":"Li Liu, Qiang Wei, Qingqing Lin, Jun Fang, Haibo Wang, Hauyee Kwok, et al. Anti\u2013spike igg causes severe acute lung injury by skewing macrophage responses during acute sars-cov infection. JCI Insight. 2019;4(4). https:\/\/doi.org\/10.1172\/jci.insight.123158.","DOI":"10.1172\/jci.insight.123158"},{"key":"10.1016\/j.vaccine.2020.04.034_b0180","doi-asserted-by":"crossref","unstructured":"Liu William J, Min Zhao, Kefang Liu, Kun Xu, Gary Wong, Wenjie Tan, et al. T-cell immunity of sars-cov: Implications for vaccine development against mers-cov. Antiviral Res. 2017;137: 82\u201392. https:\/\/doi.org\/10.1016\/j.antiviral.2016.11.006.","DOI":"10.1016\/j.antiviral.2016.11.006"},{"key":"10.1016\/j.vaccine.2020.04.034_b0185","article-title":"Flow focusing: a versatile technology to produce size-controlled and specific-morphology microparticles","volume":"4","author":"Martin-Banderas","year":"2005","journal-title":"Small"},{"key":"10.1016\/j.vaccine.2020.04.034_b0190","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human ebola virus infection results in substantial immune activation","volume":"1122","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2020.04.034_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061904","article-title":"Immunopathogenesis of severe acute respiratory disease in zaire ebolavirus-infected pigs","author":"Nfon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.04.034_b0200","doi-asserted-by":"crossref","unstructured":"Morten Nielsen, Claus Lundegaard, Peder Worning, Sanne Lise Lauem\u00f8ller, Kasper Lamberth, S\u00f8ren Buus, et al. Reliable prediction of t-cell epitopes using neural networks with novel sequence representations. Protein Sci. 2003;12 (5): 1007\u201317. https:\/\/doi.org\/10.1110\/ps.0239403.","DOI":"10.1110\/ps.0239403"},{"issue":"29","key":"10.1016\/j.vaccine.2020.04.034_b0205","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1016\/j.vaccine.2009.04.001","article-title":"Synthetic peptides coupled to the surface of liposomes effectively induce sars coronavirus-specific cytotoxic t lymphocytes and viral clearance in hla-a\u2217 0201 transgenic mice","volume":"27","author":"Ohno","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.034_b0210","doi-asserted-by":"crossref","unstructured":"Hui Peng, Li-tao Yang, Ling-yun Wang, Jian Li, Jun Huang, Zhi-qiang Lu, et al. Long-lived memory t lymphocyte responses against sars coronavirus nucleocapsid protein in sars-recovered patients. Virology. 2006;351(2): 466\u201375. https:\/\/doi.org\/10.1016\/j.virol.2006.03.036.","DOI":"10.1016\/j.virol.2006.03.036"},{"key":"10.1016\/j.vaccine.2020.04.034_b0215","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1128\/JVI.01004-14","article-title":"Hiv control is mediated in part by cd8+ t-cell targeting of specific epitopes","volume":"88","author":"Pereyra","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0220","article-title":"Ebola: an analysis of immunity at the molecular level","author":"Ponomarenko","year":"2015","journal-title":"IEEE"},{"key":"10.1016\/j.vaccine.2020.04.034_b0225","unstructured":"Michael Rasmussen, Mikkel Harndahl, Anne Bregnballe Kristensen, Ida Kallehauge Nielsen, Jorgensen Kasper W, Anette Stryhn, et al. Large scale analysis of peptide - hla-i stability. IEDB, 2014a. URL https:\/\/www.iedb.org\/reference\/1028287."},{"key":"10.1016\/j.vaccine.2020.04.034_b0230","unstructured":"Michael Rasmussen, Mikkel Harndahl, Anne Bregnballe Kristensen, Ida Kallehauge Nielsen, Jorgensen Kasper W, Anette Stryhn, et al. Large scale analysis of peptide - hla-i stability. IEDB, 2014b. URL https:\/\/www.iedb.org\/reference\/1028291."},{"key":"10.1016\/j.vaccine.2020.04.034_b0235","doi-asserted-by":"crossref","unstructured":"Sietske Rosendahl Huber, Josine van Beek, J\u00f8rgen de Jonge, Willem Luytjes, Debbie van Baarle. T cell responses to viral infections\u2013opportunities for peptide vaccination. Front Immunol. 2014;5: 171. https:\/\/doi.org\/10.3389\/fimmu.2014.00171.","DOI":"10.3389\/fimmu.2014.00171"},{"key":"10.1016\/j.vaccine.2020.04.034_b0240","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1016\/j.vaccine.2014.05.071","article-title":"Eliciting cytotoxic t-lymphocyte responses from synthetic vectors containing one or two epitopes in a c57bl\/6 mouse model using peptide-containing biodegradable microspheres and adjuvants","volume":"32","author":"Rubsamen","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.04.034_b0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-019-00584-y","article-title":"Conserved peptide vaccine candidates containing multiple ebola nucleoprotein epitopes display interactions with diverse hla molecules","volume":"208","author":"Jain","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0250","unstructured":"Saori Sakabe, Sullivan Brian M, Hartnett Jessica N, Refugio Robles-Sikisaka, Karthik Gangavarapu, Beatrice Cubitt, et al. Analysis of cd8+ t cell response during the 2013\u20132016 ebola epidemic in west africa. Proc Nat Acad Sci. 2018. ISSN 0027-8424. https:\/\/doi.org\/10.1073\/pnas.1806200115. http:\/\/www.pnas.org\/content\/early\/2018\/07\/17\/1806200115."},{"key":"10.1016\/j.vaccine.2020.04.034_b0255","doi-asserted-by":"crossref","unstructured":"Selidji MD, Agnandji T, Angela Huttner MD, Madeleine MD, Zinser E, Patricia Njuguna Med M, et al. Phase 1 trials of rvsv ebola vaccine in africa and europe. New Engl J Med New England. 2016;374: 1647\u20131660. https:\/\/doi.org\/10.1056\/NEJMoa1502924.","DOI":"10.1056\/NEJMoa1502924"},{"key":"10.1016\/j.vaccine.2020.04.034_b0260","doi-asserted-by":"crossref","unstructured":"Alessandro Sette, John Sidney, Marie-France del Guercio, Scott Southwood, J\u00f6rg Ruppert, Carol Dahlberg, et al. Peptide binding to the most frequent hla-a class i alleles measured by quantitative molecular binding assays. Mol Immunol. 1994;31(11): 813\u201322. https:\/\/doi.org\/10.1016\/0161-5890(94)90019-1.","DOI":"10.1016\/0161-5890(94)90019-1"},{"key":"10.1016\/j.vaccine.2020.04.034_b0265","unstructured":"John Sidney, Jason Botten, Benjamin Neuman, Michael Buchmeier, Alessandro Sette. Sars iedb entries. IEDB, 2006. URL https:\/\/www.iedb.org\/reference\/1000425."},{"key":"10.1016\/j.vaccine.2020.04.034_b0270","doi-asserted-by":"crossref","unstructured":"John Sidney, Scott Southwood, Carrie Moore, Carla Oseroff, Clemencia Pinilla, Grey Howard M, et al. Measurement of mhc\/peptide interactions by gel filtration or monoclonal antibody capture. Current Protocols Immunol. 2013;l100(1): 18\u20133. https:\/\/doi.org\/10.1002\/0471142735.im1803s100.","DOI":"10.1002\/0471142735.im1803s100"},{"key":"10.1016\/j.vaccine.2020.04.034_b0275","doi-asserted-by":"crossref","unstructured":"Smatti Maria K, Al Thani Asmaa A, Yassine Hadi M. Viral-induced enhanced disease illness. Front Microbiol. 2018;9: 2991. https:\/\/doi.org\/10.3389\/fmicb.2018.02991.","DOI":"10.3389\/fmicb.2018.02991"},{"key":"10.1016\/j.vaccine.2020.04.034_b0280","doi-asserted-by":"crossref","unstructured":"Sridhar S. Heterosubtypic t-cell immunity to influenza in humans: Challenges for universal t-cell influenza vaccines. Front Immunol. 2016;7 (195). https:\/\/doi.org\/10.3389\/fimmu.2016.00195.","DOI":"10.3389\/fimmu.2016.00195"},{"key":"10.1016\/j.vaccine.2020.04.034_b0285","doi-asserted-by":"crossref","unstructured":"Saranya Sridhar, Shaima Begom, Alison Bermingham, Katja Hoschler, Walt Adamson, William Carman, et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nature Med. 2013;19(10): 1305. https:\/\/doi.org\/10.1038\/nm.3350.","DOI":"10.1038\/nm.3350"},{"key":"10.1016\/j.vaccine.2020.04.034_b0290","doi-asserted-by":"crossref","unstructured":"The International HIV Controllers Study et al. The major genetic determinants of hiv-1 control affect hla class i peptide presentation. Sci (New York, NY). 2010;330(6010): 1551. https:\/\/doi.org\/10.1126\/science.1195271.","DOI":"10.1126\/science.1195271"},{"key":"10.1016\/j.vaccine.2020.04.034_b0295","doi-asserted-by":"crossref","unstructured":"Sullivan Nancy J, Sanchez Anthony, Rollin Pierre E., Yang Zhi yong, Nabel Gary J.. Development of a preventive vaccine for ebola virus infection in primates. Nature. 2000;408: 605\u2013609. https:\/\/doi.org\/10.1038\/35046108","DOI":"10.1038\/35046108"},{"key":"10.1016\/j.vaccine.2020.04.034_b0300","doi-asserted-by":"crossref","unstructured":"Sylvester-Hvid C, Nielsen Morten, Lamberth K, R\u00f8der G, Justesen S, Lundegaard C, et al. Sars ctl vaccine candidates\u2013hla supertype, genome-wide scanning and biochemical validation. Scandinavian J Immunol. 2004;59(6): 632\u2013632. https:\/\/doi.org\/10.1111\/j.0001-2815.2004.00221.x.","DOI":"10.1111\/j.0300-9475.2004.01423bd.x"},{"issue":"5","key":"10.1016\/j.vaccine.2020.04.034_b0305","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1073\/pnas.1712263115","article-title":"Ebola virus proteins np, vp35, and vp24 are essential and sufficient to mediate nucleocapsid transport","volume":"115","author":"Takamatsu","year":"2018","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.vaccine.2020.04.034_b0310","doi-asserted-by":"crossref","unstructured":"Xiaolu Tang, Changcheng Wu, Xiang Li, Yuhe Song, Xinmin Yao, Xinkai Wu, et al. On the origin and continuing evolution of sars-cov-2. National Sci Rev., 20202. page nwaa036. https:\/\/doi.org\/10.1093\/nsr\/nwaa036.","DOI":"10.1093\/nsr\/nwaa036"},{"key":"10.1016\/j.vaccine.2020.04.034_b0315","doi-asserted-by":"crossref","unstructured":"Trolle Thomas, McMurtrey Curtis P, Sidney John, Bardet Wilfried, Osborn Sean C, Kaever Thomas, et al. The length distribution of class i\u2013restricted t cell epitopes is determined by both peptide supply and mhc allele\u2013specific binding preference. J Immunol. 2016;196 (4): 1480\u201387. https:\/\/doi.org\/10.4049\/jimmunol.1501721.","DOI":"10.4049\/jimmunol.1501721"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.034_b0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbrc.2006.03.152","article-title":"Hla-a\u2217 0201 t-cell epitopes in severe acute respiratory syndrome (sars) coronavirus nucleocapsid and spike proteins","volume":"344","author":"Tsao","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2020.04.034_b0325","article-title":"The immune epitope database (iedb) 3.0","author":"Vita","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2020.04.034_b0330","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fmicb.2020.00135","article-title":"Vogel and Balaji Manicassamy. Broadly protective strategies against influenza viruses: Universal vaccines and therapeutics","volume":"11","author":"Olivia","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.034_b0335","doi-asserted-by":"crossref","unstructured":"William Wan, Larissa Kolesnikova, Mairi Clarke, Alexander Koehler, Takeshi Noda, Stephan Becker, et al. Structure and assembly of the ebola virus nucleocapsid. Nature. 2017;551(7680): 394\u201397. https:\/\/doi.org\/10.1038\/nature24490.","DOI":"10.1038\/nature24490"},{"key":"10.1016\/j.vaccine.2020.04.034_b0340","doi-asserted-by":"crossref","unstructured":"Wang F, Ono T, Kalergis A, Zhang W, DiLorenzo T, Lim K. On the defing rules for interactions between the t cell receptor and its ligand: a critical role for a specific amino acid residue of the t cell receptor b chain. Proc Natl Acad Sci USA. 1998;95(6). https:\/\/doi.org\/10.1073\/pnas.95.9.5217.","DOI":"10.1073\/pnas.95.9.5217"},{"key":"10.1016\/j.vaccine.2020.04.034_b0345","doi-asserted-by":"crossref","unstructured":"Warfield Kelly L, Dye John M, Wells Jay B, Unfer Robert C, Holtsberg Frederick W, Shulenin Sergey, et al. Homologous and heterologous protection of nonhuman primates by ebola and sudan virus-like particles. PLoS One. 2015;10 (3): e0118881. https:\/\/doi.org\/10.1371\/journal.pone.0118881.","DOI":"10.1371\/journal.pone.0118881"},{"issue":"26","key":"10.1016\/j.vaccine.2020.04.034_b0350","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","article-title":"Ebola virus-like particles protect from lethal ebola virus infection","volume":"100","author":"Warfield","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2020.04.034_b0355","doi-asserted-by":"crossref","unstructured":"Wauquier P, Becquart C, Padilla, Baize S, Leroy EM. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. Negl Trop Dis. 2010;4 (e837). https:\/\/doi.org\/10.1371\/journal.pntd.0000837.","DOI":"10.1371\/journal.pntd.0000837"},{"key":"10.1016\/j.vaccine.2020.04.034_b0360","unstructured":"Weber DJ, Rutala WA. Plotkin sa, orenstein wa, offit pa. vaccines. 6, 2013."},{"issue":"6","key":"10.1016\/j.vaccine.2020.04.034_b0365","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from ebola virus mediated by cytotoxic t lymphocytes specific for the viral nucleoprotein","volume":"75","author":"Wilson","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.034_b0370","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00894-004-0210-0","article-title":"Reasoning of spike glycoproteins being more vulnerable to mutations among 158 coronavirus proteins from different species","volume":"11","author":"Guang","year":"2005","journal-title":"J Mol Model"},{"key":"10.1016\/j.vaccine.2020.04.034_b0375","doi-asserted-by":"crossref","unstructured":"Chean Yeah Yong, Hui Kian Ong, Swee Keong Yeap, Kok Lian Ho, Wen Siang Tan. Recent advances in the vaccine development against middle east respiratory syndrome-coronavirus. Front Microbiol. 2019;10: 1781. https:\/\/doi.org\/10.3389\/fmicb.2019.01781.","DOI":"10.3389\/fmicb.2019.01781"},{"key":"10.1016\/j.vaccine.2020.04.034_b0380","doi-asserted-by":"crossref","unstructured":"Linqi Zhang, Fengwen Zhang, Wenjie Yu, Tian He, Jian Yu, Yi Christopher E, et al. Antibody responses against sars coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006;78 (1): 1\u20138. https:\/\/doi.org\/10.1002\/jmv.20499.","DOI":"10.1002\/jmv.20499"},{"key":"10.1016\/j.vaccine.2020.04.034_b0385","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4161\/hv.26088","article-title":"Advances in the study of hla-restricted epitope vaccines","volume":"9","author":"Zhao","year":"2018","journal-title":"Human Vacc Immunotherapeut"},{"issue":"4","key":"10.1016\/j.vaccine.2020.04.034_b0390","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.177.4.2138","article-title":"Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific ctl epitopes","volume":"177","author":"Zhou","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:52Z","timestamp":1759401832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":78,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20305181"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.034","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.02.25.963546","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An effective CTL peptide vaccine for Ebola Zaire Based on Survivors\u2019 CD8+ targeting of a particular nucleocapsid protein epitope with potential implications for COVID-19 vaccine design","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}